Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Chandra Pradhan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Fundamental & Clinical Pharmacology|December 4, 2008
Drug development for liver diseases: focus on picroliv, ellagic acid and curcuminC Girish, Suresh Chandra Pradhan
Fundamental & Clinical Pharmacology|December 6, 2011
Indian herbal medicines in the treatment of liver diseases: problems and promisesChandrashekaran Girish, Suresh Chandra Pradhan
Tropical Parasitology|March 20, 2013
Newer approaches to malaria controlSe Damodaran, Prita Pradhan, Suresh Chandra Pradhan
European Journal of Clinical Pharmacology|September 4, 2015
Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemiaSunitha Kodidela, Suresh Chandra Pradhan, Biswajit Dubashi, et al.
Medical Oncology (Northwood, London, England)|July 6, 2015
Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinibJose Francis, Biswajit Dubashi, Rajan Sundaram, et al.
Journal of Pharmacology & Pharmacotherapeutics|February 25, 2015
Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance studyJose Francis, Muthiah Palaniappan, Biswajit Dubashi, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2015
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patientsJose Francis, Biswajit Dubashi, Rajan Sundaram, et al.
Fundamental & Clinical Pharmacology|August 7, 2009
Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in miceC Girish, Bidhan Chandra Koner, S Jayanthi, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2012
Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapySolai Elango Damodaran, Suresh Chandra Pradhan, Gurusamy Umamaheswaran, et al.
Indian Journal of Experimental Biology|April 23, 2009
Hepatoprotective activity of six polyherbal formulations in CCl4-induced liver toxicity in miceC Girish, Bidhan Chandra Koner, S Jayanthi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Fundamental & Clinical Pharmacology|December 4, 2008
Drug development for liver diseases: focus on picroliv, ellagic acid and curcuminC Girish, Suresh Chandra Pradhan
Fundamental & Clinical Pharmacology|December 6, 2011
Indian herbal medicines in the treatment of liver diseases: problems and promisesChandrashekaran Girish, Suresh Chandra Pradhan
Tropical Parasitology|March 20, 2013
Newer approaches to malaria controlSe Damodaran, Prita Pradhan, Suresh Chandra Pradhan
European Journal of Clinical Pharmacology|September 4, 2015
Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemiaSunitha Kodidela, Suresh Chandra Pradhan, Biswajit Dubashi, et al.
Medical Oncology (Northwood, London, England)|July 6, 2015
Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinibJose Francis, Biswajit Dubashi, Rajan Sundaram, et al.
Journal of Pharmacology & Pharmacotherapeutics|February 25, 2015
Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance studyJose Francis, Muthiah Palaniappan, Biswajit Dubashi, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2015
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patientsJose Francis, Biswajit Dubashi, Rajan Sundaram, et al.
Fundamental & Clinical Pharmacology|August 7, 2009
Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in miceC Girish, Bidhan Chandra Koner, S Jayanthi, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2012
Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapySolai Elango Damodaran, Suresh Chandra Pradhan, Gurusamy Umamaheswaran, et al.
Indian Journal of Experimental Biology|April 23, 2009
Hepatoprotective activity of six polyherbal formulations in CCl4-induced liver toxicity in miceC Girish, Bidhan Chandra Koner, S Jayanthi, et al.
Pageof 2